APO RESEARCH · REPORT
1,3-Thiazolidine-2,4-Dione
1,3-Thiazolidine-2,4-Dione is a heterocyclic chemical substance identified by its named ring and substituent structure.
Product & engineering
Understand the product.
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1,3-Thiazolidine-2,4-Dione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
The commercial boundary
Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.
Which supplied interfaces and acceptance criteria define 1,3-Thiazolidine-2,4-Dione?
The full named identity, positional or stereochemical form, assay basis, impurity profile and supplied form define 1,3-Thiazolidine-2,4-Dione. Material qualification and downstream formulation acceptance are distinct requirements; report segmentation is not a supplier specification.
Selected research
Industry Research
1,3-Thiazolidine-2,4-Dione Industry Research Report 2026
Market perspective
The global 1,3-Thiazolidine-2,4-Dione market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 1,3-Thiazolidine-2,4-Dione is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 1,3-Thiazolidine-2,4-Dione is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 1,3-Thiazolidine-2,4-Dione is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 1,3-Thiazolidine-2,4-Dione include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 1,3-Thiazolidine-2,4-Dione market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 1,3-Thiazolidine-2,4-Dione.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
1,3-Thiazolidine-2,4-Dione Market by Company
ShanDong Believe Chemical
Jinan Shengqi Pharmaceutical
Hangzhou Ribo Pharmaceutical
Dezhou Haizhi Pharma
Siwei Development Group
Sarex
Robinson Brothers
1,3-Thiazolidine-2,4-Dione Segment by Type
Purity ≥98%
Purity ≥99%
Others
1,3-Thiazolidine-2,4-Dione Segment by Application
Pioglitazone Intermediate
Rosiglitazone Intermediate
Others
1,3-Thiazolidine-2,4-Dione Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 1,3-Thiazolidine-2,4-Dione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 1,3-Thiazolidine-2,4-Dione and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 1,3-Thiazolidine-2,4-Dione.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 1,3-Thiazolidine-2,4-Dione manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 1,3-Thiazolidine-2,4-Dione by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 1,3-Thiazolidine-2,4-Dione in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥98%
- Purity ≥99%
- Others
Applications
- Pioglitazone Intermediate
- Rosiglitazone Intermediate
- Others
Companies covered
- ShanDong Believe Chemical
- Jinan Shengqi Pharmaceutical
- Hangzhou Ribo Pharmaceutical
- Dezhou Haizhi Pharma
- Siwei Development Group
- Sarex
- Robinson Brothers
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 1,3-Thiazolidine-2,4-Dione by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity ≥98%
- 2.2.3 Purity ≥99%
- 2.2.4 Others
- 2.3 1,3-Thiazolidine-2,4-Dione by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pioglitazone Intermediate
- 2.3.3 Rosiglitazone Intermediate
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global 1,3-Thiazolidine-2,4-Dione Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global 1,3-Thiazolidine-2,4-Dione Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global 1,3-Thiazolidine-2,4-Dione Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 1,3-Thiazolidine-2,4-Dione Production by Manufacturers (2021-2026)
- 3.2 Global 1,3-Thiazolidine-2,4-Dione Production Value by Manufacturers (2021-2026)
- 3.3 Global 1,3-Thiazolidine-2,4-Dione Average Price by Manufacturers (2021-2026)
- 3.4 Global 1,3-Thiazolidine-2,4-Dione Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 1,3-Thiazolidine-2,4-Dione Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global 1,3-Thiazolidine-2,4-Dione Manufacturers, Product Type & Application
- 3.7 Global 1,3-Thiazolidine-2,4-Dione Manufacturers Established Date
- 3.8 Global 1,3-Thiazolidine-2,4-Dione Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ShanDong Believe Chemical
- 4.1.1 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Company Information
- 4.1.2 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.1.3 ShanDong Believe Chemical 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 ShanDong Believe Chemical Product Portfolio
- 4.1.5 ShanDong Believe Chemical Recent Developments
- 4.2 Jinan Shengqi Pharmaceutical
- 4.2.1 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Company Information
- 4.2.2 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.2.3 Jinan Shengqi Pharmaceutical 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Jinan Shengqi Pharmaceutical Product Portfolio
- 4.2.5 Jinan Shengqi Pharmaceutical Recent Developments
- 4.3 Hangzhou Ribo Pharmaceutical
- 4.3.1 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Company Information
- 4.3.2 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.3.3 Hangzhou Ribo Pharmaceutical 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Hangzhou Ribo Pharmaceutical Product Portfolio
- 4.3.5 Hangzhou Ribo Pharmaceutical Recent Developments
- 4.4 Dezhou Haizhi Pharma
- 4.4.1 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Company Information
- 4.4.2 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.4.3 Dezhou Haizhi Pharma 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Dezhou Haizhi Pharma Product Portfolio
- 4.4.5 Dezhou Haizhi Pharma Recent Developments
- 4.5 Siwei Development Group
- 4.5.1 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Company Information
- 4.5.2 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.5.3 Siwei Development Group 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Siwei Development Group Product Portfolio
- 4.5.5 Siwei Development Group Recent Developments
- 4.6 Sarex
- 4.6.1 Sarex 1,3-Thiazolidine-2,4-Dione Company Information
- 4.6.2 Sarex 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.6.3 Sarex 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Sarex Product Portfolio
- 4.6.5 Sarex Recent Developments
- 4.7 Robinson Brothers
- 4.7.1 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Company Information
- 4.7.2 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Business Overview
- 4.7.3 Robinson Brothers 1,3-Thiazolidine-2,4-Dione Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Robinson Brothers Product Portfolio
- 4.7.5 Robinson Brothers Recent Developments
5 Global 1,3-Thiazolidine-2,4-Dione Production by Region
- 5.1 Global 1,3-Thiazolidine-2,4-Dione Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global 1,3-Thiazolidine-2,4-Dione Production by Region: 2021-2032
- 5.2.1 Global 1,3-Thiazolidine-2,4-Dione Production by Region: 2021-2026
- 5.2.2 Global 1,3-Thiazolidine-2,4-Dione Production Forecast by Region (2027-2032)
- 5.3 Global 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global 1,3-Thiazolidine-2,4-Dione Production Value by Region: 2021-2032
- 5.4.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Region: 2021-2026
- 5.4.2 Global 1,3-Thiazolidine-2,4-Dione Production Value Forecast by Region (2027-2032)
- 5.5 Global 1,3-Thiazolidine-2,4-Dione Market Price Analysis by Region (2021-2026)
- 5.6 Global 1,3-Thiazolidine-2,4-Dione Production and Value, YOY Growth
- 5.6.1 North America 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan 1,3-Thiazolidine-2,4-Dione Production Value Estimates and Forecasts (2021-2032)
6 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region
- 6.1 Global 1,3-Thiazolidine-2,4-Dione Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region (2021-2032)
- 6.2.1 Global 1,3-Thiazolidine-2,4-Dione Consumption by Region: 2021-2026
- 6.2.2 Global 1,3-Thiazolidine-2,4-Dione Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa 1,3-Thiazolidine-2,4-Dione Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa 1,3-Thiazolidine-2,4-Dione Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global 1,3-Thiazolidine-2,4-Dione Production by Type (2021-2032)
- 7.1.1 Global 1,3-Thiazolidine-2,4-Dione Production by Type (2021-2032) & (t)
- 7.1.2 Global 1,3-Thiazolidine-2,4-Dione Production Market Share by Type (2021-2032)
- 7.2 Global 1,3-Thiazolidine-2,4-Dione Production Value by Type (2021-2032)
- 7.2.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global 1,3-Thiazolidine-2,4-Dione Production Value Market Share by Type (2021-2032)
- 7.3 Global 1,3-Thiazolidine-2,4-Dione Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global 1,3-Thiazolidine-2,4-Dione Production by Application (2021-2032)
- 8.1.1 Global 1,3-Thiazolidine-2,4-Dione Production by Application (2021-2032) & (t)
- 8.1.2 Global 1,3-Thiazolidine-2,4-Dione Production Market Share by Application (2021-2032)
- 8.2 Global 1,3-Thiazolidine-2,4-Dione Production Value by Application (2021-2032)
- 8.2.1 Global 1,3-Thiazolidine-2,4-Dione Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global 1,3-Thiazolidine-2,4-Dione Production Value Market Share by Application (2021-2032)
- 8.3 Global 1,3-Thiazolidine-2,4-Dione Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 1,3-Thiazolidine-2,4-Dione Value Chain Analysis
- 9.1.1 1,3-Thiazolidine-2,4-Dione Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 1,3-Thiazolidine-2,4-Dione Production Mode & Process
- 9.2 1,3-Thiazolidine-2,4-Dione Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 1,3-Thiazolidine-2,4-Dione Distributors
- 9.2.3 1,3-Thiazolidine-2,4-Dione Customers
10 Global 1,3-Thiazolidine-2,4-Dione Analyzing Market Dynamics
- 10.1 1,3-Thiazolidine-2,4-Dione Industry Trends
- 10.2 1,3-Thiazolidine-2,4-Dione Industry Drivers
- 10.3 1,3-Thiazolidine-2,4-Dione Industry Opportunities and Challenges
- 10.4 1,3-Thiazolidine-2,4-Dione Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst